Companies fined for selling drugs with unclear origin

Update: April, 17/2015 - 16:31

HA NOI (VNS) — The Drug Administration of Viet Nam under the Health Ministry has fined two foreign pharmaceutical companies more than VND300 million (US$14,000) after recently discovering violations in their drug sales.

The Austin Pharma Specilities Company was fined VND160 million for selling omeprazole and pantoprazole of unclear origin. The company was also forced to submit the US$30,625 earned from the sales of the drugs.

The administration has also decided to annul all the drugs registered by the company. Medicines produced by the company have also been banned from being imported into Viet Nam for the next two years.

CSPC Innovation Pharmaceutical Company, the other penalised company, was fined VND160 million for the same violation.

The administration also put aside CSPC's application for importing drugs for the next two years.

Omeprazole and pantoprazole are proton pump inhibitors that decrease the amount of acid produced in the stomach.

They can be used to treat erosive esophagitis (damage to the oesophagus from stomach acid), and other conditions involving excess stomach acid. — VNS